Opportunities in BioTech as Investors Bail Out of the Sector

Share it with your friends Like

Thanks! Share it with your friends!


Biotech stocks are once again lower after leading Wednesday’s market sell-off as investors jump out of the sector as fast as they can. Andrew McDonald is the co-portfolio manager of BioShares exchange traded funds and says now is a buying opportunity. McDonald says to take advantage of pullbacks to get into a sector that has been rewarding investors handsomely in recent months saying ‘valuations have increased and in certain speculative stocks, valuations are excessive but current run in market isn’t a bubble.’ A few of McDonald’s favorite picks in biotech include ZS Pharma (ZSPH), Gilead Sciences (GILD) and Anacor Pharmaceuticals (ANAC).

Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV

For more content from TheStreet visit: http://thestreet.com
Check out all our videos: http://youtube.com/user/TheStreetTV
Follow TheStreet on Twitter: http://twitter.com/thestreet
Like TheStreet on Facebook: http://facebook.com/TheStreet
Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet
Follow TheStreet on Google+: http://plus.google.com/+TheStreet


StockTradingMaster says:

Yes and look at the selling too. The sell side dollar volume is over +200% greater than the 50 MA on biotech stock ETFs like IBB. Massive amounts of short biotech stocks are in-play in Bear market etfs like BIS https://www.guerillastocktrading.com/stocks/trader-alert-get-out-of-biotech-stocks/

Comments are disabled for this post.